.png?sfvrsn=1a7df424_3)
Process Development & Scale-up
How a process is designed and integrated determines its overall costs and risk profile. Early validation of the performance of an end-to-end process will de-risk technology transfer to a cGMP setting.
BTI has sufficient infrastructure to integrate single- and multi-use unit operations up to 50 litres under pre-cGMP conditions. To alleviate traditional bottlenecks and improve process efficiency, BTI is developing scaled-down models to study selected unit operations and create novel unit operations.
Visit the following webpages for more information:
- Animal Cell Bioprocessing
- Biomanufacturing Devices
- Biomanufacturing Technology
- Cell Line Development
- Downstream Processing
- Stem Cell Bioprocessing
A*STAR celebrates International Women's Day
From groundbreaking discoveries to cutting-edge research, our researchers are empowering the next generation of female science, technology, engineering and mathematics (STEM) leaders.